Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck KGaA (OTC Pink - Current Information:MKGAY)

Delayed Data
As of Jul 29
 +0.20 / +0.55%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Merck KGaA engages in the manufacturing of pharmaceutical and chemical products. The company operates through following divisions: Healthcare, Performance Materials and Life Science, which comprise the Groups six businesses. The Healthcare division is sub divided into Biopharmaceuticals and Consumer Health divisions. The Biopharmaceuticals division discovers, develops, manufactures and markets pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility and growth disorders, as well as certain cardiovascular and metabolic diseases. The Consumer Health division is an over-the-counter drug business primarily focused on Europe, with a growing presence in emerging markets. The Performance Materials division engages in the chemicals business that offers high-tech performance chemicals for applications in fields such as consumer electronics, lighting, coatings, printing, plastics, and cosmetics. The Life Science division has a broad product and technology portfolio and offers solutions for scientists and engineers in the life science industry. Merck was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Contact Information

Merck KGaA
Frankfurter Straße 250
Darmstadt Hessen 64293
Investor Relations:



Other institutional0.04%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Stefan OschmannChief Executive Officer
Marcus KuhnertChief Financial Officer
Laszlo RadvanyiSenior Vice President & Head-Research
Bernd ReckmannChief Executive Officer-Chemicals Business
Belén Garijo LópezMember-Executive Board